INNOVATION
IN
NANOTECHNOLOGY
We develop solutions to unsolved problems of medicine with the use of unique patent-protected nanotechnology.
Our innovations focus on human blood substitutes and targeted cancer therapies.
NEWS
Michal Lach has bet millions on a WSE biotech group that recently came close to insolvency. NanoGroup is also supported by other investors. The entire article, by Mariusz Bartodziej, is worth reading in Puls Biznesu. Valued at over PLN 20 million on the WSE (at its peak, even several times higher), NanoGroup was in 2022. […]
NanoGroup S.A. has entered into an agreement with eCapital sp. z o.o., based in Warsaw (Investor), an investment agreement. The Investment Agreement states that: a. 809,524 new issue shares – provided that at least one autotransplantation confirming the effectiveness of the NanoOX system has been carried out, by which the parties to the Investment Agreement […]
The Management Board of NanoGroup S.A. has received offers from investors interested in acquiring series L shares issued (on the basis of the resolution of the Extraordinary General Meeting of March 11, 2024, adopted to raise bridge financing) to purchase shares for a total issue price of PLN 1,440,000. In addition, one of the investors […]
MEDICINE OF TOMORROW
NanoGroup has two development pillars, both targeting critical unsolved medical needs.
RESPIRATORY GASES
EXCHANGE FLUIDS
NANOVELOS PLATFORM:
POLYSACCHARIDE NANOCAPSULES
FOR TARGETED THERAPIES
RESPIRATORY GASES
EXCHANGE FLUIDS
NANOVELOS PLATFORM:
POLYSACCHARIDE NANOCAPSULES
FOR TARGETED THERAPIES
CAREER
Do you set yourself ambitious scientific goals? Do you want to take part in bio-tech and nano-tech medical projects?
NanoGroup is a platform of competence and specialists who share a believe that groundbreaking technologies responding to pressing global challenges can emerge and be developed in Poland.
If you want to join our team, go ahead to contact us!